QQ客服 官方微博 反馈留言

	Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
	Wu, Jianzhang[1]; Wu, Shoubiao[1]; Shi, Lingyi[1]; Zhang, Shanshan[1]; Ren, Jiye[1]; Yao, Song[1]; Yun, Di[1]; Huang, Lili[1]; Wang, Jiabing[1]; Li, Wulan[1,2]
	2017
卷号	125期号:[db:dc_citation_issue]页码:1321
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3361911
专题	暨南大学
作者单位	1.[1]Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China 2.[2]Wenzhou Med Univ, Clin Med Coll 1, Coll Informat Sci & Comp Engn, Wenzhou 325035, Zhejiang, Peoples R China 3.[3]Jinan Univ, Key Lab Mol Immunol & Antibody Engn Guangdong Pro, Guangdong Higher Educ Inst, Inst Tissue Transplantat & Immunol,Key Lab Funct, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Wu, Jianzhang[1],Wu, Shoubiao[1],Shi, Lingyi[1],et al. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer[J],2017,125([db:dc_citation_issue]):1321.
APA	Wu, Jianzhang[1].,Wu, Shoubiao[1].,Shi, Lingyi[1].,Zhang, Shanshan[1].,Ren, Jiye[1].,...&Liang, Guang[1].(2017).Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer.,125([db:dc_citation_issue]),1321.
MLA	Wu, Jianzhang[1],et al."Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer".125.[db:dc_citation_issue](2017):1321.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。